Commerzbank has lifted its net profit target for the year to at least €3.4 billion, up from a previous goal of €3.2 billion, underscoring the lender’s confidence in its standalone earnings power. The upgrade came despite a slight dip in net interest income during the first quarter, which fell to €2.047 billion — just shy of the €2.06 billion analysts had pencilled in. Strong growth in fee-based income, however, helped push operating profit up 11% to €1.358 billion, with after-tax net income landing at €913 million.
The brighter outlook lands at a moment when the bank is fighting a rearguard action against UniCredit’s creeping takeover bid. Andrea Orcel, the Italian bank’s chief executive, has now amassed a potential economic interest of around 38% in Commerzbank — roughly 26.77% held directly and a further 10.91% tendered by June 9, following 7.58% in the prior week. When instruments such as derivatives are included, the figure approaches 41%.
Yet Commerzbank’s management, led by chief executive Bettina Orlopp and supervisory board chairman Jens Weidmann, has cast serious doubt on the legitimacy of that tender progress. They allege that a mere 0.05% of the shares tendered came from retail investors. The rest, they suspect, were delivered by banks with close business ties to UniCredit — Nomura among them. The accusation: a lack of transparency and a “false game”. The bank has called in Germany’s financial regulator, BaFin, to investigate a reported tenfold surge in securities lending since the offer was launched.
The political dimension is equally charged. Berlin, which still holds a 12% stake, has labelled the bid “inappropriate”. The vice-president of the European Central Bank, meanwhile, has criticised German resistance as an obstacle to deeper financial integration in Europe. Economically, the scepticism is understandable. UniCredit’s exchange offer — 0.485 of its own shares for each Commerzbank share — provides no real takeover premium; it actually values the target below its current market price. With Commerzbank’s market capitalisation hovering near €40 billion, the bid clearly fails to reflect that worth.
Should investors sell immediately? Or is it worth buying Commerzbank?
On the trading floor, the stock has held up remarkably well. At €36.26, with a 0.53% gain on the day, it sits just 5% below a 52-week high of €38.15 touched in early June. Over the past twelve months it has climbed roughly 31%, much of that fuelled by takeover speculation. The technical picture remains constructive: the price remains above both the 50-day moving average of €35.54 and the 200-day line at €33.80. The relative strength index stands at about 50 — a neutral position that suggests no imminent breakout in either direction.
Wednesday’s ECB rate meeting in Frankfurt now injects fresh uncertainty. A cautious tone from the central bank could dampen the margin expectations that have propped up bank stocks. Conversely, a stable interest-rate outlook would support Commerzbank’s ambitious profit targets. The market will watch the 2:15 pm decision and the following macroeconomic projections closely.
The real risk, however, is political and regulatory. Should BaFin find irregularities in the tender process, or should Berlin stiffen its opposition, the speculative premium baked into Commerzbank’s share price could evaporate quickly. Analysts at JPMorgan argue that Orcel will not be able to secure effective control without sweetening the offer. For anyone betting on a revised bid, the provisional tender deadline of June 16 will be the next critical test — one that pits Orcel’s determination against a bank that is now posting higher earnings and pushing back harder.
Ad
Commerzbank Stock: Buy or Sell?! New Commerzbank Analysis from June 11 delivers the answer:
The latest Commerzbank figures speak for themselves: Urgent action needed for Commerzbank investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 11.
Commerzbank: Buy or sell? Read more here...
